过去一年中添加的文章,按日期排序
Suppression of NLRP3 inflammasome orchestrates the protective efficacy of tiron against isoprenaline-induced myocardial injury
2 天前 - … The major contribution of myocardial damage to global mortalities arouses debate
regarding the exploration of new therapeutic strategies for its treatment. Therefore, our study …
regarding the exploration of new therapeutic strategies for its treatment. Therefore, our study …
Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway
A Wang, G Zhong, M Ying, Z Fang, Y Chen, H Wang… - …, 2024 - Elsevier
4 天前 - … Notably, the use of MCC950 in Parkin +/- mice did not ameliorate NLRP3 inflammasome
… NLRP3 inflammasome activation is expected to be a potential therapeutic strategy for …
… NLRP3 inflammasome activation is expected to be a potential therapeutic strategy for …
[HTML][HTML] DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering
O Sandys, PCF Stokkers, AA Te Velde - Digestive Diseases and Sciences, 2024 - Springer
6 天前 - … strategy that addresses its variability. One approach often overlooked by the
pharmaceutically driven therapeutic … , for example, the NLRP3 inflammasome—a major amplifier …
pharmaceutically driven therapeutic … , for example, the NLRP3 inflammasome—a major amplifier …
UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier
L Ran, M Chen, J Ye, S Zhang, Z Luo, T Bai… - Advanced …, 2024 - Wiley Online Library
9 天前 - … NLRP3 inflammasome has been recognized as a promising therapeutic strategy for
the … Here, it is shown that UK5099 is a potent inhibitor of the NLRP3 inflammasome in both …
the … Here, it is shown that UK5099 is a potent inhibitor of the NLRP3 inflammasome in both …
Unraveling the Triad: Hypoxia, Oxidative Stress and Inflammation in Neurodegenerative Disorders
15 天前 - … therapeutic approach for age-related brain diseases. Recent findings indicate that
the involvement of HIF-1α and the NLRP3 inflammasome … Additional therapy strategies aimed …
the involvement of HIF-1α and the NLRP3 inflammasome … Additional therapy strategies aimed …
[HTML][HTML] Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes
J Guan, H Abudouaini, K Lin, K Yang - Diabetology & Metabolic Syndrome, 2024 - Springer
15 天前 - … therapeutic potential of IL-1 inhibitors and colchicine, highlighting their mechanisms
in inhibiting the NLRP3 inflammasome … implementing targeted therapeutic strategies aimed …
in inhibiting the NLRP3 inflammasome … implementing targeted therapeutic strategies aimed …
Development of CRID3-Based Anti-inflammatory Agents to Ameliorate Chronic Hypoxia-Induced Memory Impairment in Zebrafish Models
K Soren, RK Bollikanda, T Das, S Patel… - ACS Chemical …, 2024 - ACS Publications
20 天前 - … In this study, we focused on the NLRP3 inflammasome … molecule inhibitors for the
NLRP3 inflammasome, to investigate … in developing therapeutic strategies for neurological …
NLRP3 inflammasome, to investigate … in developing therapeutic strategies for neurological …
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
B Li, P Li, L Wei, J Zou, Y Wang, Q You… - Journal of Medicinal …, 2024 - ACS Publications
22 天前 - … Targeting NLRP3 inflammasome, specifically its interaction with NEK7 via the
LRR domain of NLRP3, is a promising therapeutic strategy. Our research aimed to disrupt this …
LRR domain of NLRP3, is a promising therapeutic strategy. Our research aimed to disrupt this …
Platelets in Kawasaki disease: mediators of vascular inflammation
M Noval Rivas, B Kocatürk, BS Franklin… - Nature Reviews …, 2024 - nature.com
23 天前 - … Platelets boost NLRP3 inflammasome activation and IL-1β production by human …
disease vasculitis and therapeutic strategies targeting platelets or platelet-derived molecules. …
disease vasculitis and therapeutic strategies targeting platelets or platelet-derived molecules. …
[HTML][HTML] Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant …
W Ke, J Wu, H Li, S Huang, H Li, Y Wang, Y Wu, J Yuan… - Heliyon, 2024 - cell.com
23 天前 - … κB/NLRP3 inflammasome pathway … /NLRP3 signaling pathway. This study not only
reveals the mechanism of CJAF against IBS-D, but also provides a novel therapeutic strategy …
reveals the mechanism of CJAF against IBS-D, but also provides a novel therapeutic strategy …
相关搜索
- nlrp3 inflammasome in rheumatoid arthritis
- nlrp3 inflammasome in astrocytes
- human nlrp3 inflammasome
- nlrp3 inflammasome inhibitor
- nlrp3 inflammasome activation
- microglial exosomes nlrp3 inflammasome
- therapeutic potential nlrp3 inflammasome
- receptor pathway nlrp3 inflammasome
- alzheimer's disease model nlrp3 inflammasome
- hypobaric hypoxia nlrp3 inflammasome
- cognitive deficits nlrp3 inflammasome
- social interaction nlrp3 inflammasome
- positive regulation nlrp3 inflammasome
- cognitive impairment nlrp3 inflammasome
- narrative review nlrp3 inflammasome